Mark Hyman Rapaport, MD, Professor, joined the department January 1, 2021 as new Chairman of the Department of Psychiatry and CEO of the Huntsman Mental Health Institute (HMHI). Dr. Rapaport serves as the second William H. and Edna D. Stimson Presidential Endowed Chair, University of Utah School of Medicine.
From 2011-2020, Dr. Rapaport was Chairman of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and Chief of Psychiatric Services at Emory Healthcare in Atlanta, Georgia. Prior to that appointment, he was the Chairman of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center and a Professor of Psychiatry at both Cedar-Sinai and the David Geffen School of Medicine at UCLA. He was the first holder of the Polier Chair while at Cedars-Sinai and also previously served as Director of the Mental Health Outpatient Clinical Research Center in the Department of Psychiatry at University of California, San Diego. He served as the first Chair of the National Institute on Drug Abuse (NIDA) Clinical Trials Network's Data Safety Monitoring Board and Chair of its Special Review Committee and also serves on NIH and NIMH Review Committees.
Dr. Rapaport has received peer-reviewed grant funding from the National Institute of Mental Health (NIMH), the National Center for Complimentary and Alternative Medicine, The Stanley Medical Research Institute, the Veterans Affairs Research Board and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Foundation. His research interests focus on human psychoneuroimmunology, psychopharmacology research, clinical trial methodology, quality of life, and complementary and alternative medicine. Dr. Rapaport has trained and mentored students, physicians and researchers in the fields of psychopharmacology, outcomes research, and psychoneuroimmunology for over 30 years.
Dr. Rapaport's written over 200 articles for such peer-reviewed publications as The American Journal of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry and Neuropsychopharmacology. He currently serves as Editor of Focus: The Journal of Lifelong Learning in Psychiatry, published by American Psychiatric Association Publishing, Inc. and the American Psychiatric Association. Dr. Rapaport is a member of the American College of Psychiatrists, American Society of Clinical Psychopharmacology, Anxiety Disorders Association of America, the Psychiatric Research Society and the Collegium International Neuropsychopharmacology (CINP) and the American College of Neuropsychopharmacology (ACNP). He is a distinguished fellow of the American Psychiatric Association and the CINP. Dr. Rapaport is board certified in Psychiatry by the American Board of Psychiatry and Neurology (1987-present).
